期刊文献+

FcγRIIb blockage:a promising immunotherapy target for severe COVID-19

原文传递
导出
摘要 A recent study published in Nature by Combes et al.1 introduced a whole-blood-preserving single-cell analysis strategy to explore the contributions of the immune cells,including neutrophils,monocytes,platelets,and lymphocytes.The team comprehensively analyzed a variety of cellular and serological immune features between severe and mild to moderate phenotypes of patients with coronavirus disease 2019(COVID-19),in order to identify potential targets of immunotherapies for the severe COVID-19 patients who need prompt and effective treatments.
出处 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2021年第5期1396-1398,共3页 信号转导与靶向治疗(英文)
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部